Clinical Trial Update: Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites [Phase 1]

View source ↗

Summary

Phase I trial update for intraperitoneal bevacizumab in refractory malignant ascites; no status or results details are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Ascites

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Peking University | Conditions: Refractory Malignant Ascites | Phase 1 | Status: UNKNOWN